AB Science
OTCMKTS:ABSCFAB Science S.A., a pharmaceutical company, engages in the research, development, and marketing of protein kinase inhibitors for use in human and veterinary medicines. Its lead compound is the masitinib, a tyrosine kinase inhibitor that is in Phase III clinical trials for the treatment of prostate and pancreatic cancer, amyotrophic lateral sclerosis, multiple sclerosis, Alzheimer's, severe asthma, and mastocytosis diseases, as well as in Phase II clinical trial to treat Covid-19. The company is also developing AB8939, a synthetic microtubule destabiliser for haematology indications. The company markets its masitinib under the Masivet brand in Europe. AB Science S.A. was incorporated in 2001 and is headquartered in Paris, France.
Agraflora Organics International
CNSX:AGRAAgraFlora Organics International Inc. operates in the cannabis industry in Canada and the Republic of Colombia. The company was formerly known as PUF Ventures Inc. and changed its name to AgraFlora Organics International Inc. in November 2018. The company was incorporated in 2004 and is headquartered in Vancouver, Canada.
Abattis Bioceuticals
CNSX:ATTAbattis Bioceuticals Corp. is a specialty biotechnology company. The Company aggregates, incubates, integrates and invests in the natural health product and botanical drug development industry. It operates through the segment of producing, licensing and marketing ingredients and formulas for use in the biopharma, nutraceutical, cosmetic and animal nutrition markets. The Company, through its subsidiaries, develops and commercializes natural health (nutraceutical) products, and conducts research and development to create plant-based (botanical) intellectual property and ingredients for the pharmaceutical and bioceutical markets, among others. It offers products and services, such as botanical blends and formulas; cannabidiol ingredients; functional foods and beverages, and analytical services. It is focused on creating botanical formulations, medical marijuana and specialized health products for pain caused by inflammation, and mental ailments.
Vidaroo
OTCMKTS:VIDAVidaroo Corporation, a video technology company, engages in licensing an online video platform and performing professional video production activities. It operates and licenses an online video platform under a software-as-a-service model that consists of a series of Web-based applications, a centralized user console, and an application for the management of the platform. The company's video platform is divided into two editions comprising Publisher, which is divided into a series of modules; and Enterprise edition that allows management of multiple content destinations. It licenses its video platform in on-demand and enterprise programs. The company's video platform provides video management, live streaming, content delivery and syndication, player functionality, social destination, analytics, and advertising capabilities. It is also involved in the creation and support of video imagery in the entertainment business; and support of video production for traditional media and corporate presentations, and in-house production of content. The company was formerly known as Gen2Media Corporation and changed its name to Vidaroo Corporation in April 2010. Vidaroo Corporation was incorporated in 2010 and is based in Winter Garden, Florida.